4530 — Hisamitsu Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual income statement for Hisamitsu Pharmaceutical Co, fiscal year end - February 28th, JPY millions except per share, conversion factor applied.

	2021 February 28th	2022 February 28th	2023 February 28th	2024 February 29th	2025 February 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	114,510	120,193	128,330	141,706	156,006
Cost of Revenue
Gross Profit	69,173	70,067	72,700	78,971	91,196
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	103,837	111,136	116,942	129,385	137,454
Operating Profit	10,673	9,057	11,388	12,321	18,552
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	12,197	12,956	16,113	19,186	28,687
Provision for Income Taxes
Net Income After Taxes	9,433	9,863	12,126	14,432	22,302
Minority Interest
Net Income Before Extraordinary Items
Net Income	9,251	9,659	11,743	13,971	21,759
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	9,250	9,658	11,742	13,969	21,758
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	111	122	147	191	301
Dividends per Share
Special Dividends per Share